|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:1517-1522
© 2005 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka, Japan
b Department of Cardio-Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom
Received for publication April 9, 2005; revisions received April 9, 2005; accepted for publication April 9, 2005. * Address for reprints: Toshikatsu Yagihara, MD, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan (Email: yagihara{at}hsp.ncvc.go.jp).
| Abstract |
|---|
|
|
|---|
METHODS: Of 202 patients subjected to the Fontan operation since 1996, the conduit was used in 28 patients who had intact pericardium. We retrospectively reviewed a consecutive series of these patients, and serial changes in conduit geometry were accessed in 16 patients who underwent catheter examinations twice at 1.1 ± 0.4 and 4.5 ± 1.4 years postoperatively.
RESULTS: There was one early and one late death. Except for a patient with apicocaval juxtaposition in whom a conduit occlusion developed caused by compression between the vertebral bodies and the ventricle, there were no important complications. Angiographically, conduit volume, estimated by using the MULTI-SLICE method, increased significantly (3490 ± 2166 to 5426 ± 3081 mm3, P < .001), whereas the volume per body weight remained unchanged. Conduit diameter increased significantly at both the inferior vena caval end (16.8 ± 4.8 to 19.8 ± 4.8 mm, P < .001) and the pulmonary artery end (11.9 ± 3.8 to 14.2 ± 4.2 mm, P < .001), whereas the diameter indexed to the normal right pulmonary artery remained unchanged. The cross-sectional area of the conduit increased in parallel with that of the normal right pulmonary artery. The ratio of the widest to the narrowest diameter of the conduit exhibited no significant change.
CONCLUSIONS: Midterm results of the Fontan operation with pedicled autologous pericardial roll were favorable. Proportional increase of conduit size was demonstrated, with its shape preserved. This suggested a potential of the conduit to grow and that growth correlated with somatic development.
| Introduction |
|---|
|
|
|---|
|
Surgical repair with native tissue has widened the indications of congenital cardiovascular surgery and has gained increasingly widespread application to various reconstructive procedures. Autologous pericardium has been used for construction of a cavopulmonary connection in the Fontan operation, with the expectation of possible growth ability and less thrombogenicity of the conduit.
1-6
Although favorable midterm outcomes have been reported,
7
no clinical study has quantitatively evaluated serial changes in conduit shape and size. Our objective was to examine midterm results of the Fontan operation using a pedicled pericardial conduit, with special attention to angiographic evaluation of serial changes in conduit geometry.
| Patients and Methods |
|---|
|
|
|---|
Information regarding the late status of patients was obtained from medical records. Median duration of follow-up was 5.5 years (range, 1.2-8.4 years). All surviving patients have been followed up postoperatively in our outpatient clinic.
Surgical Procedure
The chest was opened through a median sternotomy, and the pleural space of the corresponding side was opened widely. A sufficiently large rectangular flap of pericardium was cut, leaving it pedicled to preserve its vascular connections, with care taken not to injure the phrenic nerve. The flap was then rolled into a tube shape with a running suture of 6-0 polypropylene with minimal tension and relatively rough pitch to maintain the blood supply to PAPR (Figure 1, A). Intraoperative measurements of PAPR diameter in the 28 patients were 16 mm in 2, 17 mm in 2, 18 mm in 12, 19 mm in 1, 20 mm in 8, 22 mm in 2, and 26 mm in 1. The length of the PAPR conduit was determined on the basis of the distance between the inferior vena cava (IVC) and the PA.
|
Anticoagulation
Anticoagulation therapy with warfarin sodium and dipyridamole was continued until 1 year postoperatively. The international normalized ratio was maintained at around 2.0. The duration of dipyridamole administration was determined by the patient's personal pediatrician, although indefinite continuation of dipyridamole was recommended when compliance could be predicted and there were no obvious contraindications.
Angiographic Evaluation
Of the 28 patients with the PAPR conduit, 16 underwent catheter examinations twice at 1.1 ± 0.4 and 4.5 ± 1.4 years postoperatively. During this period, their body weight and body surface area increased significantly (body weight: 12.4 ± 2.6 to 19.1 ± 3.4 kg, P < .001; body surface area: 0.5 ± 0.1 to 0.8 ± 0.1 m2, P < .001). PAPR diameter, cross-sectional area, and volume were measured, and serial changes of these parameters were compared with somatic growth. As control subjects, 18 patients with an artificial graft as an extracardiac conduit who underwent postoperative catheter studies twice were evaluated. Graft volume was estimated by using the MULTI-SLICE method, which is usually used for ventricular volumetry. Each graft was traced in both frontal and lateral views, and the selected structure was divided into 32 cross-sections (Figure E1). Finally, cross-sectional areas of each slice were integrated to calculate graft volume. The ratio of the widest to the narrowest diameter of the PAPR conduit was estimated in either the frontal or lateral view to determine proportional change in the PAPR conduit (Figure E2). Three individuals (I.A., T.Y., and K.K.) determined the measurement points individually to eliminate subjectivity of examiner measurements. Furthermore, all procedures of measurement, such as diameter calculation and graft tracing, were repeated 3 times in each case to minimize potential sources of error from manual maneuvers, and mean values of the 3 measurements were used as final discrete values. All angiographic measurements were performed with DCM View3 angiogram software (Climb Medical System).
|
|
| Results |
|---|
|
|
|---|
Angiographic Evaluation
PAPR volume increased significantly (3490 ± 2166 to 5426 ± 3081 mm3, P < .001), whereas artificial graft volume decreased significantly (6210 ± 2795 to 5853 ± 2481 mm3, P = .026). PAPR volume per body weight remained unchanged (286 ± 173 to 282 ± 155 mm3/kg, P = .775). PAPR diameter increased significantly at both the IVC and PA ends (IVC: 16.8 ± 4.8 to 19.8 ± 4.8 mm, P < .001; PA: 11.9 ± 3.8 to 14.2 ± 4.2 mm, P < .001). However, when PAPR diameter was indexed to normal right PA diameter, it remained unchanged at both the IVC and PA ends (IVC: 162% ± 46% to 160% ± 35%, P = .722; PA: 114% ± 36% to 114% ± 31%, P = .963). The ratio of the widest to the narrowest diameter of the PAPR conduit exhibited no significant change in either the frontal or lateral view (frontal: 2.0 ± 0.8 to 1.9 ± 0.7, P = .495; lateral: 1.9 ± 0.7 to 2.0 ± 0.6, P = .759; Figure 2). The cross-sectional area of the narrowest portion of the PAPR conduit increased in parallel with that of the normal right PA (Figure 3). Neither aneurysmal change nor stenosis of the PAPR conduit was observed, and no pressure gradient was detected across the PAPR conduit in any patient except for 1 patient in whom conduit occlusion developed.
|
|
| Discussion |
|---|
|
|
|---|
In our study significant increases in PAPR volume and diameter between the 2 postoperative angiographies were demonstrated quantitatively. However, when these values were indexed to somatic parameters, the indexed values remained unchanged. The cross-sectional area of the PAPR conduit increased nearly in parallel with that of the normal right PA. These findings indicated that a significant increase in PAPR size was correlated with somatic development. Furthermore, invariability of PAPR proportion was demonstrated, although in previous studies use of autologous pericardium as an implant for vascular substitute yielded mixed results, including shrinkage caused by fibrosis with retraction or thinning with dilatation.
12
Despite the difficulty in clearly distinguishing between growth and mere dilatation, the potential of the PAPR conduit to grow was suggested by the proportional increase in conduit size with preservation of shape.
Some discrepancy was found in PAPR conduit diameters between angiographic examination and intraoperative findings. The angiographic mean value of the PA end diameter at the first catheter examination (11.9 ± 3.8 mm) was 36% less than the intraoperative measurement (18.6 ± 1.3 mm). This phenomenon can be regarded as a result of pericardial remodeling rather than shrinkage because a significant increase in diameter was demonstrated over time. In other words, we might observe the intrinsic adjustability of the PAPR conduit, which has the ability to vary its own shape in response to the flow amount passing through it.
The obvious disadvantage of this modification is its limited application. In fact, we could use the technique in less than 14% (28/202) of patients undergoing Fontan completion over the 9-year period of this study because of the lack of intact pericardium. There were no other anatomic limitations that prevented us from using this technique in the majority of our patients undergoing the Fontan operation. However, apicocaval juxtaposition might be considered as a contraindication of this technique because PAPR was more vulnerable to external compression than a rigid artificial graft.
A potential disadvantage of the geometric approach to measuring graft volume on angiographic studies is possible variability in calculated volume from observer to observer when the graft region of interest is drawn manually or when the anastomotic lines of the graft are defined manually. This is a major problem in the type of angiographic examinations performed in the present study because of the inherently overly smooth anastomotic lines resulting from construction of pathways using only native tissue. Three individuals determined the measurement points individually in the present study to eliminate subjectivity of examiner measurement, and as a result, there was little interobserver variation. Furthermore, little intraobserver variability was noted, although all procedures of measurement, such as diameter calculation and graft tracing, were repeated 3 times in each case to minimize potential sources of error from manual maneuvers.
In conclusion, midterm results of the Fontan operation with a PAPR conduit were favorable. Proportional increase of conduit size was demonstrated, with its shape preserved. This suggests a potential of the conduit to grow and that growth correlated with somatic development.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Ochiai, Y. Imoto, M. Sakamoto, T. Kajiwara, A. Sese, M. Watanabe, T. Ohno, and K. Joo Mid-term follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Goetz, T. E. Tan, K. H. Lim, F. Xiong, S. L. H. Salgues, N. Grousson, Y. L. Chua, and J. H. Yeo Autologous pericardial pulmonary conduit with single point attached commissures in a sheep model Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Adachi, T. Yagihara, K. Kagisaki, I. Hagino, T. Ishizaka, J. Kobayashi, S. Kitamura, and H. Uemura Preoperative small pulmonary artery did not affect the midterm results of Fontan operation Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 156 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, C.-H. Lee, S. W. Hwang, H. G. Lim, S.-J. Kim, J. Y. Lee, W.-S. Shim, and W.-H. Kim Midterm follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1008 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Adachi, H. Ishibashi-Ueda, T. Yagihara, K. Kagisaki, I. Hagino, T. Ishizaka, and H. Uemura Immunohistologic examination of pedicled autologous pericardium 9 years after implantation for an extracardiac conduit in Fontan pathway: Comparison with in situ pericardium and pulmonary arterial tissue from the same patient J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1101 - 1103. [Full Text] [PDF] |
||||
![]() |
A. Nakahira, T. Yagihara, K. Kagisaki, I. Hagino, T. Ishizaka, M. Koh, H. Uemura, and S. Kitamura Partial anomalous pulmonary venous connection to the superior vena cava. Ann. Thorac. Surg., September 1, 2006; 82(3): 978 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Adachi, T. Yagihara, H. Ishibashi-Ueda, and S. Kitamura Immunohistological findings for an extracardiac conduit in Fontan pathway constructed with pedicled autologous pericardium. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 1059 - 1060. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |